- $664.56m
- $686.09m
- $380.72m
- 38
- 66
- 73
- 61
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M |
Source: | PROSPECTUS | PROSPECTUS | 10-K | 10-K |
Standards: | USG | USG | USG | USG |
Status: | Final | Final | Final | Final |
Revenue | ||||
Total Revenue | 109 | 228 | 246 | 381 |
Cost of Revenue | ||||
Gross Profit | 59.6 | 159 | 119 | 236 |
Selling / General / Administrative Expenses | ||||
Research And Development | ||||
Depreciation and Amortization | ||||
Unusual Expense / Income | ||||
Other Operating Expenses | ||||
Total Operating Expenses | 264 | 184 | 272 | 504 |
Operating Profit | -155 | 44.2 | -25.7 | -124 |
Total Net Non Operating Interest Income / Expense | ||||
Other Net Non Operating Costs | ||||
Net Income Before Taxes | -163 | 52.5 | -7.67 | -104 |
Net Income After Taxes | -163 | 52.5 | -7.67 | -104 |
Net Income Before Extraordinary Items | ||||
Net Income | -163 | 52.5 | -7.67 | -104 |
Income Available to Common Shareholders Excluding Extraordinary Items | ||||
Income Available to Common Shareholders Including Extraordinary Items | ||||
Diluted Net Income | -163 | 52.5 | -7.67 | -104 |
Diluted Weighted Average Shares | ||||
Basic EPS Including Extraordinary Items | ||||
Diluted EPS Including Extraordinary Items | ||||
Diluted EPS Excluding Extraordinary Items | ||||
Normalised Income Before Taxes | ||||
Normalised Income After Taxes | ||||
Normalised Income Available to Common Shareholders | ||||
Diluted Normalised EPS | -0.971 | 1.75 | -0.249 | 3.95 |
Dividends per Share |